PAVmed to Hold a Business Update Conference Call and Webcast on March 25, 2025
Rhea-AI Summary
PAVmed (Nasdaq: PAVM, PAVMZ), a diversified commercial-stage medical technology company, has announced a business update conference call and webcast scheduled for March 25, 2025, at 8:30 AM ET.
During the call, Chairman and CEO Lishan Aklog, M.D., will provide a business update and overview of company operations and growth strategy. President and CFO Dennis McGrath will discuss fourth quarter 2024 financial results.
- U.S. callers can dial 1-800-836-8184
- International callers can dial 1-646-357-8785
- Conference name: 'PAVmed Business Update'
A 30-day replay will be available in the investor relations section at pavmed.com following the call.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, PAVMZ gained 12.73%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Conference Call and Webcast at 8:30 AM Eastern Time
The webcast will be available at the investor relations section of the Company's website at pavmed.com. Alternatively, to access the conference call by telephone,
Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at pavmed.com.
About PAVmed
PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer to mitigate the risks of esophageal cancer deaths. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. Veris is concurrently developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris Cancer Care Platform.
For more and for more information about PAVmed, please visit pavmed.com.
For more information about Lucid Diagnostics, please visit luciddx.com.
For more information about Veris Health, please visit verishealth.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/pavmed-to-hold-a-business-update-conference-call-and-webcast-on-march-25-2025-302396797.html
SOURCE PAVmed Inc.
FAQ
When is PAVmed's Q4 2024 earnings call scheduled for?
How can investors access PAVmed's March 2025 business update call?
How long will PAVmed's Q4 2024 earnings call replay be available?
Who will be presenting at PAVmed's March 2025 business update call?
